Invesco Ltd. Alaunos Therapeutics, Inc. Transaction History

Invesco Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $37,743 - $114,150	-92,057 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $1,817 - $3,430	-2,932 Reduced 3.09%	92,057 $60,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $8,334 - $14,450	-7,646 Reduced 7.45%	94,989 $104,000
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $23,711 - $44,952	16,466 Added 19.11%	102,635 $188,000
Q2 2021 Aug 17, 2021	BUY	$2.63 - $3.67 $90,995 - $126,978	34,599 Added 67.09%	86,169 $227,000
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $27,619 - $54,846	9,794 Added 23.44%	51,570 $186,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $62,618 - $92,579	29,961 Added 253.58%	41,776 $105,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $1,422 - $2,040	595 Added 5.3%	11,815 $30,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $211 - $356	96 Added 0.86%	11,220 $37,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $91,844 - $240,728	-48,339 Reduced 81.29%	11,124 $27,000
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $234,878 - $318,127	59,463 New	59,463 $281,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $1.84 Million - $3.1 Million	-446,376 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $1.78 Million - $2.77 Million	446,376 New	446,376 $2.6 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.